A sensor-assisted wearable digital monitoring system and method providing site-specific adaptive thermal support for the management of chemotherapy-related neurotoxic symptoms.

TR202614446A2Pending Publication Date: 2026-09-21T C USKUDAR UNIVERSITESI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TR202614446
Authority / Receiving Office
TR · TR
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-08-25
Publication Date
2026-09-21

Smart Images

  • Figure 00000029_0000
    Figure 00000029_0000
  • Figure 00000029_0001
    Figure 00000029_0001
Patent Text Reader

Abstract

The invention relates to the treatment of neurotoxic agents used in chemotherapy in the field of oncology, particularly... Platinum-based and taxane group drugs such as oxaliplatin and paclitaxel cause nerve damage in peripheral nerves. Prevention and reduction of symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN) and to create vasoconstriction in the hand / foot areas for digital management session / time-triggered adaptive cooling for pharyngolaryngeal / perioral / neck region Event / sensor-triggered adaptive heating strategies to prevent dysesthesia in a single system. wearable medical device and Edge AI-powered digital health platform It is concerned with a system (1) and method combined in its architecture.
Need to check novelty before this filing date? Find Prior Art